Model Driven Method for exploring Individual and Confounding Effects in Spontaneous Adverse Event Reporting Databases

Author:

Lv Bo1,Li Yuedong1,Shi Aiming1,Pan Jie1

Affiliation:

1. The Second Affiliated Hospital of Soochow University

Abstract

Abstract Background Spontaneous Adverse Event Reporting (SAER) databases play a crucial part in post-marketed drug surveillance. The reported odds ratio (ROR) is commonly used to detect the significant signal of AE-drug combinations. However, the typical ROR may be biased by heterogeneity from individual factors such as gender and age. In addition, confounding biases render the typical ROR far from indicative of causality. Therefore, these issues urgently require solutions. Methods Model driven ROR (MD-ROR) was proposed as an alternative to typical ROR to explore individual and confounding effects in SAER databases. Unlike the traditional 2*2 cross table approach, our method employed Poisson regression with two-way interactions to estimate the MD-ROR, which was shown to be equivalent to typical ROR. Subsequently, we introduce the MD-ROR under three-way interaction to reveal the heterogeneity behind pooled crude ROR and to identify subgroup effects on the signals of AE-drugs. We also introduce adjusted MD-ROR to address confounding biases by flexibly defining confound effects in the model. To test our methods, the simulation data and FDA Adverse Event Reporting System (FAERS) database were both used. Result The simulated data suggested the subgroup effects estimated by MD-ROR were unbiased and efficient. Additionally, the adjusted MD-ROR was more robust against confounding biases than crude ROR. Application of our method to FAERS database showed differences in drug interaction and cardiac adverse events between males and females for Midazolam existed. In addition, the AE-drug combinations, Midazolam-septic shock and Midazolam-depression, were found overestimated potentially due to confounding biases from gender. Conclusion Our study highlighted that MD-ROR is a promising method for exploring individual and confounding effects in SAER databases. Our method provides a bridge between SAER databases and flexibly customized models.

Publisher

Research Square Platform LLC

Reference21 articles.

1. In Silico Pharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined Classifiers;Cai C;J Chem Inf Model,2018

2. Niimura T, Miyata K, Hamano H, Nounin Y, Unten H, Yoshino M, Mitsuboshi S, Aizawa F, Yagi K, Koyama T et al. Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase). Drug safety 2023.

3. Pneumocystis jirovecii pneumonia associated with immune checkpoint inhibitors: A systematic literature review of published case reports and disproportionality analysis based on the FAERS database;Xia S;Front Pharmacol,2023

4. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System;Stobaugh DJ;J Am Acad Dermatol,2013

5. The reporting odds ratio and its advantages over the proportional reporting ratio;Rothman KJ;Pharmacoepidemiol Drug Saf,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3